How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

8,613 results for

Mobile Medical Applications

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

8301. Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy

or planned pregnancy; concurrent medical conditions that could affect treatment; significant respiratory impairment; treatment with IVIg, corticosteroids or plasma-exchange in the 6 weeks before treatment; multifocal motor neuropathy; and failure to respond to IVIg or corticosteroids. Setting The setting was secondary care and a hospital. The economic study was carried out in several European countries. Dates to which data relate The effectiveness and resource use data were gathered from July 1998 (...) The analysis of the clinical study appears to have been restricted to treatment completers only. The primary outcome measures used were improvements in disability scores and quality of life. Disability scores were assessed using an 11-point scale. Quality of life was examined using the EuroQol EQ-5D instrument, which contains five domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). The study groups were comparable at baseline. Effectiveness results There were

2003 NHS Economic Evaluation Database.

8302. Ultrasound for bone mineral density

as medical advice and intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance the information. The production of this Horizon scanning prioritising summary was overseen by the Health Policy Advisory Committee on Technology (HealthPACT), a sub-committee of the Medical Services Advisory (...) of Adelaide, Adelaide, SA, 5005. PRIORITISING SUMMARY REGISTER ID: 000343 (REFERRAL) NAME OF TECHNOLOGY: ULTRASOUND FOR ASSESSMENT OF RISK OF FRACTURE PURPOSE AND TARGET GROUP: OSTEOPOROSIS DIAGNOSIS STAGE OF DEVELOPMENT (IN AUSTRALIA): Yet to emerge Established Experimental Established but changed indication or modification of technique Investigational Should be taken out of use ? Nearly established AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION APPROVAL ? Yes ARTG number 98149 No Not applicable

2007 Australia and New Zealand Horizon Scanning Network

8303. EarPopper for the treatment of otitis media with effusion in children

or completeness of the information in this summary. This summary is not intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information. The production of this Horizon scanning prioritising summary was overseen by the Health (...) Policy Advisory Committee on Technology (HealthPACT), a sub-committee of the Medical Services Advisory Committee (MSAC). HealthPACT comprises representatives from health departments in all states and territories, the Australia and New Zealand governments; MSAC and ASERNIP-S. The Australian Health Ministers’ Advisory Council (AHMAC) supports HealthPACT through funding. This Horizon scanning prioritising summary was prepared by Adriana Parrella, Janet Hiller and Linda Mundy from the National Horizon

2005 Australia and New Zealand Horizon Scanning Network

8304. Remote monitoring systems for implantable cardiac devices

. The Commonwealth does not guarantee the accuracy, currency or completeness of the information in this summary. This summary is not intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information. The production of this Horizon (...) scanning prioritising summary was overseen by the Health Policy Advisory Committee on Technology (HealthPACT), a sub-committee of the Medical Services Advisory Committee (MSAC). HealthPACT comprises representatives from health departments in all states and territories, the Australia and New Zealand governments; MSAC and ASERNIP-S. The Australian Health Ministers’ Advisory Council (AHMAC) supports HealthPACT through funding. This Horizon scanning prioritising summary was prepared by Tom Sullivan, Linda

2006 Australia and New Zealand Horizon Scanning Network

8305. Earpopper for the treatment of otitis media in children (update)

, currency or completeness of the information in this summary. This summary is not intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information. The production of this Horizon scanning prioritising summary was overseen (...) by the Health Policy Advisory Committee on Technology (HealthPACT), a sub-committee of the Medical Services Advisory Committee (MSAC). HealthPACT comprises representatives from health departments in all states and territories, the Australia and New Zealand governments; MSAC and ASERNIP-S. The Australian Health Ministers’ Advisory Council (AHMAC) supports HealthPACT through funding. This Horizon scanning prioritising summary was prepared by Adriana Parrella, Linda Mundy and Janet Hiller from the National

2007 Australia and New Zealand Horizon Scanning Network

8306. Activecare DVT for the prevention of deep vein thrombosis

, currency or completeness of the information in this summary. This summary is not intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information. The production of this Horizon scanning prioritising summary was overseen (...) by the Health Policy Advisory Committee on Technology (HealthPACT), a sub-committee of the Medical Services Advisory Committee (MSAC). HealthPACT comprises representatives from health departments in all states and territories, the Australia and New Zealand governments; MSAC and ASERNIP-S. The Australian Health Ministers’ Advisory Council (AHMAC) supports HealthPACT through funding. This Horizon scanning prioritising summary was prepared by Tom Sullivan and Janet Hiller from the National Horizon Scanning

2007 Australia and New Zealand Horizon Scanning Network

8307. SMS text messaging

is not intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information. The production of this Horizon scanning prioritising summary was overseen by the Health Policy Advisory Committee on Technology (HealthPACT), a sub (...) -committee of the Medical Services Advisory Committee (MSAC). HealthPACT comprises representatives from health departments in all states and territories, the Australia and New Zealand governments; MSAC and ASERNIP-S. The Australian Health Ministers’ Advisory Council (AHMAC) supports HealthPACT through funding. This Horizon scanning prioritising summary was prepared by Tom Sullivan and Janet Hiller from the National Horizon Scanning Unit, Adelaide Health Technology Assessment, Discipline of Public Health

2007 Australia and New Zealand Horizon Scanning Network

8308. Screening for Chlamydia in pharmacies

. This summary is not intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information. The production of this Horizon scanning prioritising summary was overseen by the Health Policy Advisory Committee on Technology (HealthPACT (...) ), a sub-committee of the Medical Services Advisory Committee (MSAC). HealthPACT comprises representatives from health departments in all states and territories, the Australia and New Zealand governments; MSAC and ASERNIP-S. The Australian Health Ministers’ Advisory Council (AHMAC) supports HealthPACT through funding. This Horizon scanning prioritising summary was prepared by Linda Mundy and Janet Hiller from the National Horizon Scanning Unit, Adelaide Health Technology Assessment, Discipline

2007 Australia and New Zealand Horizon Scanning Network

8309. Rapid point-of-care for the detection of Chlamydia in individuals at risk of trachoma

. The Commonwealth does not guarantee the accuracy, currency or completeness of the information in this summary. This summary is not intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information. The production of this Horizon (...) scanning prioritising summary was overseen by the Health Policy Advisory Committee on Technology (HealthPACT), a sub-committee of the Medical Services Advisory Committee (MSAC). HealthPACT comprises representatives from health departments in all states and territories, the Australia and New Zealand governments; MSAC and ASERNIP-S. The Australian Health Ministers’ Advisory Council (AHMAC) supports HealthPACT through funding. This Horizon scanning prioritising summary was prepared by Linda Mundy

2006 Australia and New Zealand Horizon Scanning Network

8310. Pre-hospital administration of antibiotics by paramedics for suspected cases of meningococcal disease

of the health technology covered. The Commonwealth does not guarantee the accuracy, currency or completeness of the information in this summary. This summary is not intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a health professional's advice. The Commonwealth does not accept any liability for any injury, loss or damage incurred by use of or reliance (...) on the information. The production of this Horizon scanning prioritising summary was overseen by the Health Policy Advisory Committee on Technology (HealthPACT), a sub-committee of the Medical Services Advisory Committee (MSAC). HealthPACT comprises representatives from health departments in all states and territories, the Australia and New Zealand governments; MSAC and ASERNIP-S. The Australian Health Ministers’ Advisory Council (AHMAC) supports HealthPACT through funding. This Horizon scanning prioritising

2006 Australia and New Zealand Horizon Scanning Network

8311. The Acutely or Critically Sick or Injured Child in the District General Hospital

CriticalSickChild txt 26/10/06 16:46 Page iDH INFORMATION READER BOX Policy HR/Workforce Management Planning Clinical Estates Performance IM&T Finance Partnership working Document purpose For information Gateway reference 6369 Title The acutely or critically sick or injured child in the district general hospital: A team response Authors DH, RCPCH, RCoA, RCN, RCS, APA and BAPS Publication date October 2006 Target audience NHS trust CEs, foundation trust CEs and medical directors Circulation list Strategic health (...) authority CEs and emergency care leads Description An inter-collegiate expert working group has considered issues regarding anaesthetic and other services available to children who are critically sick or injured in district general hospitals, and has produced this report. It was open to consultation between August and December 2005 and was finalised with the benefit of comments received. Cross-reference N/A Superseded documents N/A Action required N/A Timing N/A Contact details Dr Edward Wozniak Medical

2006 Royal College of Anaesthetists

8312. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

issue of the Journal of the American College of Cardiology, the September 5, 2006 issue of Circulation, andtheSeptember17,2006issueoftheEuropeanHeartJournal)areavailablefromOxfordUniversityPressbycontactingSpecialSales,JournalsDivision,Oxford University Press, Great Clarendon Street, Oxford, OX2 6DP, UK. Telephone þ44 (0)1865 353827, Fax þ44 (0)1865 353774, work mobile þ44 (0)7841 322925, or e-mail special.sales@oxfordjournals.org. Single copies of the executive summary and the full-text guidelines (...) professionals to make appropriate decisions in the circumstances of the individual patients, in consultation with that patient, and where appropriate and necessary the patient’s guardian or carer. It is also the health professional’s responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription. Downloaded from https://academic.oup.com/europace/article-abstract/8/9/746/534498 by guest on 02 April 2019Table of Contents Preamble 749 1. Introduction 750 1.1

2006 European Society of Cardiology

8313. The meaning clinical pathway of the operation for thyroid tumour and parotid tumour

and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study examined a clinical pathway (CP) for the management of operations for thyroid and parotid tumours. The CP employed standardised pre- and postoperative management, using a series of printed orders with instructions on such matters as treatment, examination, diet and mobility of the patients. Type of intervention Treatment. Economic study type Cost-effectiveness (...) The implementation of a clinical pathway (CP) for thyroid and parotid tumours is beneficial as it enables a reduction in the length of hospitalisation and the medical costs, while maintaining the quality of operation and patient care. CRD COMMENTARY - Selection of comparators The rationale for the choice of the comparator was clear. The intervention was adequately described in the paper, but the comparator was not described. This limits the validity of the analysis as the reader would be unable to determine

2004 NHS Economic Evaluation Database.

8314. Costs and consequences of botulinum toxin type A use: management of children with cerebral palsy in Germany

, electroencephalogram, hospital inpatient stay per day in ward 3 and 7, microbiological test, occupational therapy session, outpatient visit, physiotherapy session, stool assessment, surgical procedure for muscle lengthening, surgical procedure for tendon lengthening, tendon release or tendon transfer, urinalysis and X-ray. The economic analysis also included orthotic and mobility aid costs, as well as medication costs (e.g. anaesthetic, analgesic, anti-asthmatic, antibiotic, anticoagulant, anti-emetic, anti (...) % of patients in the botulinum group and 68% in the control group needed a new orthotic. The total costs were reported per patient. The total costs during the first year of treatment were Euro 16,700 per child treated in the botulinum toxin group, while the equivalent cost in the control group was Euro 33,800. The length of hospital stay and the cost of orthotics and mobility aids collectively accounted for 88% of the cost of treating patients in both groups. Synthesis of costs and benefits Not applicable

2004 NHS Economic Evaluation Database.

8315. Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease

on a specific ethnic minority group of Bangladeshi patients and consists of a multifaceted model where an individual's beliefs about self-efficacy operate with their goals and expectations about the outcome of their actions to influence self-care behaviour. The programme comprised 6, 3-hour sessions over six weeks, and took place in general practices or community centres. The sessions covered topics including symptom management, communication with health professionals, managing medication, exercise (...) included participants who had attended three or more of the six education sessions. The primary outcome measure was self-efficacy, which was measured using six items from the Chronic Disease Self-Efficacy Scale. These items were general condition management, distress, non-medication management, discomfort, fatigue, and interference. Secondary outcomes were firstly self-management behaviour and communication with the doctor, which were assessed using scales from the same instrument, measuring use

2005 NHS Economic Evaluation Database.

8316. Nurse entrepreneurs - turning initiative into independence

position in the market 4 – How to trade: legal form of business 8 – Franchises 10 – Choosing the right equipment 13 4Money matters 14 – Accountants, tax, insurance and pensions 14 – RCN indemnity insurance cover 15 – Financing your business 16 – Using your own money 16 – Charges and fees 19 – Negotiating payment 20 – Payment and invoicing 20 5 Some business opportunities 22 – Aero-medical in-flight nursing 22 – Education and training 22 – Management 23 – Primary health care 24 – Podiatry 24 – Research (...) their cars, and is it accessible for people with disabilities? ? Providing refreshments, reading materials and toys for children can make a good first impression for clients. If you are using your home as your practice base, think about how your family and your clients will cope with each other’s presence and how you will deal with distractions ? If you are practising in the community, making sure clients can reach you is vital. Mobile phones, voicemail services or answering machines, plus email

2007 Royal College of Nursing

8317. Clinical practice guideline: The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care

, an individual's potential to develop pressure ulcers may be influenced by the following intrinsic risk factors: ? reduced mobility or immobility ? sensory impairment ? acute illness ? level of consciousness ? extremes of age ? previous history of pressure damage ? vascular disease ? severe chronic or terminal illness ? malnutrition. Extrinsic factors include pressure, shearing, friction, medication, and moisture to the skin. 3.4 What are pressure-relieving devices? There are two main approaches to preventing (...) Institute Stakeholder involvement The following stakeholders commented on draft versions of these guidelines: 3M Healthcare Ltd Abbott Laboratories Ltd All W ales Medical and Pharmaceutical Advisers Forum Ambulance Service Association British Association for Parenteral and Enteral Nutrition (BAPEN) British Association of Plastic Surgeons British Association for Prosthetists and Orthotists British Dietetic Association British Geriatrics Society British Medical Association – Hospital Doctors Secretariat

2007 Royal College of Nursing

8318. Guidance for mentors of student nurses and midwives. An RCN toolkit

students with a wide variety or impairments and disabilities. Some of the more common include: ? dyslexia and/or dyscalculia ? epilepsy ? hearing or visual impairments ? progressive medical conditions ? mental health conditions ? physical disability and/or restricted mobility. The legal framework The Disability Discrimination Act (1995) This groundbreaking legislation outlawed discrimination against disabled people for the first time. With a primary focus on employment and access to good services (...) for at least one year before taking on this role. 4 GU IDA NCE FO R M E NTO RS ROYA L C OLL E G E OF N U RS I N G 5 2 The role of mentor As a mentor you are required to offer the student support and guidance in the practice area. Your role is to enable the student to make sense of their practice through: ? the application of theory ? assessing, evaluating and giving constructive feedback ? facilitating reflection on practice, performance and experiences. All mentors, and others involved in supporting

2005 Royal College of Nursing

8319. Ankle sprains in the paediatric athlete

% and foot x-rays by 29% . The Ottawa ankle rules An ankle x-ray series is only necessary if there is pain in the malleolar zone and any of the following: Bone tenderness at the posterior edge or tip of the lateral malleolus, or Bone tenderness at the posterior edge or tip of the medical malleolus, or Inability to weight bear both immediately and in the emergency department A foot x-ray series is only necessary if there is pain in the midfoot zone and any of the following: Bone tenderness at base (...) of immobilization . In fact, a 20% decline in strength has been shown for each week of immobilization . Functional bracing, with early mobilization, provides support and stability, allowing for earlier improvements in range of motion, earlier return to sport, and higher patient satisfaction when compared with immobilization . Rigid lateral stirrups may be used acutely. When returning to sport, a functional brace such as a lace-up ankle brace should be worn for the first three to six months to protect the ankle

2007 Canadian Paediatric Society

8320. Physical activity for people with cardiovascular disease: recommendations of the National Heart Foundation of Australia

Physical activity for people with cardiovascular disease: recommendations of the National Heart Foundation of Australia Physical activity for people with cardiovascular disease: recommendations of the National Heart Foundation of Australia | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login (...) muscle fitness and, for survivors of acute myocardial infarction, lower mortality. The greatest potential for benefit is in those people who were least active before beginning regular physical activity, and this benefit may be achieved even at relatively low levels of physical activity. Medical practitioners should routinely provide brief, appropriate advice on physical activity to people with well-compensated, clinically stable cardiovascular disease. Background and evidence base for recommendations

2006 MJA Clinical Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>